Anticancer Drugs Oncology Pharmacology Physiotherapy Toremifene


In this article we will discuss Toremifene (Dosage Overview)

In this article, we will discuss Toremifene (Dosage Overview). So, let’s get started.


Toremifene is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in
postmenopausal women with estrogen-receptor positive or unknown tumors.


The dosage of Toremifene is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.